
Opinion|Videos|April 22, 2024
Dyskinesia: Importance of Giving Patients More Good “On- Time" In Parkinson’s Disease
Drs Isaacson, Pahwa, and Gupta discuss the management of dyskinesia and providing good ON time in Parkinson’s disease, sharing practical tips for early identification and treatment of dyskinesia, as well as their experience with current treatments.
Advertisement
Timecodes:
1:28 Defining ON time in PD
4:50 Dyskinesia experience
8:00 Tremor and dyskinesia
13:30 Dyskinesia and QoL
16:00 Dyskinesia and OFF
19:30 Tailoring treatment
22:00 Amantadine DR/ER
29:00 Amantadine candidates
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Roche Unveils PrevenTRON, a Phase 3 Prevention Trial of Trontinemab in Cognitively Unimpaired Individuals at High Risk of Alzheimer Decline
2
Sanofi's Oral TREM2 Agonist SAR448851 Advances to Phase 2 TREMHANCE Trial in Early Alzheimer Disease
3
Alzheimer's Association Launches PROTECT-Cog Combination Prevention Trial
4
This Week on NeurologyLive® — July 20, 2026
5


















